Trial Profile
Phase II Clinical Trial of Antigen pulsed dendritic cells (APDC) combined with chemotherapy in the treatment for metastatic colorectal cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Apr 2016
Price :
$35
*
At a glance
- Drugs Colorectal cancer vaccine (Primary) ; Dendritic cells; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Colorectal cancer
- Focus Therapeutic Use
- 21 May 2012 Actual end date (10 Jun 2008) added as reported by Chinese Clinical Trial Register record.
- 21 Mar 2012 Status changed from recruiting to completed as reported by Chinese Clinical Trial Register.
- 26 Nov 2011 New trial record